Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population

Pharmacogenetics

Volumn 11, Issue 1, 2001, Pages 39-44

  Loriot, M A ^a   Rebuissou, S ^a   Oscarson, M ^a   Cenee S ^a   Miyamoto, M ^a   Ariyoshi, N ^a   Kamataki, T ^a   Hemon D ^a   Beaune, P ^a   Stucker I ^a  

^a INSERM   (France)

Author keywords

Cytochrome P450 2A6; Genetic polymorphism; Lung cancer; Tobacco consumption

Indexed keywords

CYTOCHROME P450 2A6; DNA; NICOTINE; NITROSAMINE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; FRANCE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; TOBACCO DEPENDENCE;

ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DNA LIGASES; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIXED FUNCTION OXYGENASES; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SMOKING;

EID: 17744381734     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200102000-00005     Document Type: Article

References (21)

1. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C
2. Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
3. Nicotine dependence and tolerance in man: Pharmacokinetic and pharmacodynamic investigations
4. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method
5. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
6. Tobacco smoke carcinogens and lung cancer
7. The significance of the homozygous CYP2A6 deletion on nicotine metabolism: A new genotyping method of CYP2A6 using a single PCR-RFLP
8. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
9. Genetic variation of CYP2A6, smoking, and risk of cancer
10. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity
11. CYP2A6 gene deletion reduces susceptibility to lung cancer
12. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes
13. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyI-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502)
14. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
15. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
16. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine alpha-hydroxylation by human liver microsomes
17. Environment and cancer: Who are susceptible?
18. Molecular epidemiology of environmental carcinogenesis
19. Nicotine metabolism defect reduces smoking
20. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
21. CYP2D6 genotype and lung cancer risk according to histologic type and tobacco exposure